Novavax, Inc. - Common Stock (NQ:NVAX)

9.150 -0.250 (-2.66%)

Delayed Quote Updated: 9:44 AM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Novavax, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm

October 28, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Novavax, Inc. and Encourages Investors to Contact the Firm

October 20, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth

September 04, 2024

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:NVAX),(NASDAQ:RGNX),(NASDAQ:BNTX),(NYSE:ABBV) EQNX::TICKER_END

Via FinancialNewsMedia

Novavax Inc. (NASDAQ: NVAX) Near the Top of Equities by Percentage Gain on 7/10

July 10, 2023

Via Investor Brand Network

New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth

September 04, 2024

From FN Media Group LLC

Via GlobeNewswire

Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?

August 19, 2024

Biotechnology company Moderna Inc. (NASDAQ: MRNA) stock rocked investors with a 30% drop following its second-quarter 2024 earnings release.

Via MarketBeat

Novavax Inc. (NASDAQ: NVAX) Leading the Way in Tuesday Trading Based on Percentage Gain

May 09, 2023

Via Investor Brand Network

Novavax Plunges on Earnings Miss: Falling Knife or Buying Opp?

August 12, 2024

Novavax Inc. (NASDAQ: NVAX) is a biotechnology company that focuses on developing and commercializing vaccines for serious infectious diseases.

Via MarketBeat

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Rises in After-Hours Trading Following Major UK Contracts and FDA Progress

June 26, 2024

Via AB Newswire

Topics Economy

GameStop Raises $2.14 Billion, Meme Stocks Buzz Fuels Gains Watch: GME, PRSO, DYAI, VTAK, AMC

June 13, 2024

Via AB Newswire

Top 4 Large-Cap Stocks With Major Short Interest

June 13, 2024

As meme stock mania continues, stocks with high short interest like Novavax, Upstart, C3.ai, and Comstock Resources may attract renewed interest.

Via MarketBeat

Spotlight June 2024: NASDAQ Stocks Under $2 Achieving Major Milestones TELL, DYAI, PRSO, SPEC, GME

June 11, 2024

Via AB Newswire

Topics Energy

Meme Stocks Surge Led by ‘Roaring Kitty’ and Social Media Buzz on Reddit (NYSE: RDDT), GME, DYAI, AMC, PRSO, NVAX

June 06, 2024

Via AB Newswire

Novavax Stock’s Recent Surge and Future Potential

June 06, 2024

Novavax's future hinges on its ability to translate recent stock market momentum into sustained financial performance.

Via MarketBeat

Topics Economy

Dyadic International Inc. (NASDAQ: DYAI) Hits New 52-Week High Amidst Golden Cross, Bullish Swing Patterns and Bird Flu Concerns

June 06, 2024

Via AB Newswire

Peraso Inc. (NASDAQ: PRSO) Announces Paradigm-Shifting mmWave Wi-Fi Advancements with Phased Array Antenna Technology

June 06, 2024

Via AB Newswire

Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns

May 30, 2024

Via AB Newswire

Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting

May 20, 2024

From Shah Capital

Via GlobeNewswire

5 Meme Stocks With a High Short Interest

May 14, 2024

Keith Gill, aka RoaringKitty, resurfaces on Twitter, triggering a surge in GameStop and AMC Entertainment shares amid remarkable trading volume.

Via MarketBeat

Topics Economy

Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting

May 06, 2024

From Shah Capital

Via GlobeNewswire

Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report

May 06, 2024

After a painful two-year selloff, Pfizer shareholders may have finally gained a foothold after the company delivered a solid Q1 2024 earnings report

Via MarketBeat

Shah Capital nominates two highly qualified independent director candidates for Novavax

April 15, 2024

From Shah Capital

Via GlobeNewswire

The Top 5 Analysts Ranked by Marketbeat and Stocks They Cover

April 09, 2024

Analysts rate the stocks, but who rates the analysts? This is a look at five of the highest-rated analysts tracked by Marketbeat.com based on 12-month ROI.

Via MarketBeat

Topics Cannabis

Exploring Stocks with High Short Interest: INBS, BLNK, BYND, NVAX, PLUG

February 27, 2024

Via AB Newswire

Topics Electric Vehicles

Novavax’s dispute resolution and upcoming earnings call

February 23, 2024

Novavax navigates legal settlements, earnings expectations, and competition, hoping their protein-based vaccines become a global health game-changer.

Via MarketBeat

Topics Earnings

2 Stocks That Doubled EPS Estimates and Flashing Buy Signals

September 01, 2023

The second quarter of the 2023 earnings season has drawn to a close. There were many surprises in every sector. However, there were some standout surprises with

Via MarketBeat

Is Novavax Finally Turning Things Around?

May 15, 2023

Vaccine developer Novavax Inc. (NASDAQ: NVAX) stock shot up 28% following its Q1 2023 earnings report. The company specializes in vaccines for infectious disea

Via MarketBeat

A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats

March 20, 2023

By Ernest Dela Aglanu, Benzinga

Via TheNewswire.com

Topics Death Economy

Coronavirus Vaccine Market To Surpass $95 Billion By 2028

February 28, 2023

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

Via FinancialNewsMedia

MarketBeat Week in Review – 1/30 - 2/3

February 04, 2023

The markets are trending lower to end the week. It’s hard to figure out the markets after the blockbuster job report, but the MarketBeat team gave it a shot

Via MarketBeat

Topics Artificial Intelligence Earnings Economy

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.